.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200175

« Back to Dashboard
NDA 200175 describes TRIBENZOR, which is a drug marketed by Daiichi Sankyo and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the TRIBENZOR profile page.

The generic ingredient in TRIBENZOR is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are forty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.

Summary for NDA: 200175

Tradename:
TRIBENZOR
Applicant:
Daiichi Sankyo
Ingredient:
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 200175

Suppliers and Packaging for NDA: 200175

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIBENZOR
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL 200175 NDA Sun Pharmaceutical Industries, Inc. 57664-796 57664-796-83 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (57664-796-83)
TRIBENZOR
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL 200175 NDA Sun Pharmaceutical Industries, Inc. 57664-796 57664-796-99 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (57664-796-99)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE;12.5MG;20MG
Approval Date:Jul 23, 2010TE:ABRLD:No
Patent:5,616,599*PEDPatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?Y

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE;12.5MG;40MG
Approval Date:Jul 23, 2010TE:ABRLD:No
Patent:5,616,599*PEDPatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?Y

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE;25MG;40MG
Approval Date:Jul 23, 2010TE:ABRLD:No
Patent:5,616,599*PEDPatent Expiration:Oct 25, 2016Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 200175

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo
TRIBENZOR
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL200175-001Jul 23, 20105,616,599*PED► subscribe
Daiichi Sankyo
TRIBENZOR
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL200175-005Jul 23, 20105,616,599*PED► subscribe
Daiichi Sankyo
TRIBENZOR
amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL200175-004Jul 23, 20105,616,599*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc